<div class="__aliyun_email_body_block"><div  style="clear:both;"><span  style="font-family:tahoma;font-size:14.0px;">Hi all,</span></div><div  style="clear:both;"><span  style="font-family:tahoma;font-size:14.0px;">Free webinar from Shuimu Biosciences: Technical Advances and Applications of Cryo-EM at CET 9:00-10:00AM on 20th July.</span></div><div  style="clear:both;"><span  style="font-family:tahoma;font-size:14.0px;">To register the webinar,</span><a href="https://urldefense.proofpoint.com/v2/url?u=https-3A__zoom.us_webinar_register_9816257229754_WN-5FOAMdm9wqRhqRvkco9d85fg&d=DwMGaQ&c=-35OiAkTchMrZOngvJPOeA&r=L7-zyQ-04fFCMRqzLIOnx7H0exGZHwIQe_wMPuY600I&m=67_i6D-lSWpyF5P0O9rAxkSIhxB6bb_NQBtiUrt8W6c&s=z3-lh9gBeIvJlTBQdu3wGZwE0_4XWTCh0wx3S9_3B4s&e=" target="_blank" style="text-decoration:underline;font-family:tahoma;font-size:14.0px;"><span  style="font-family:tahoma;font-size:14.0px;">please click here</span></a><span  style="font-family:tahoma;font-size:14.0px;">.</span></div><div  style="clear:both;"><br ></div><div  style="clear:both;"><span  style="font-family:tahoma;font-size:14.0px;">This webinar will walk you through the advances and applications of cryo-EM technology, especially focus on examples on how resolution revolution can help on facilitating drug development of both small molecule drugs and antibodies.</span></div><div  style="clear:both;"><br ></div><div  style="clear:both;"><span  style="font-family:tahoma;font-size:14.0px;">The speaker is Dr. Xiaodan Ni, senior scientist in cryo-EM and structural biology at Shuimu Biosciences. She obtained her PhD degree at Mcmaster University in Canada in 2017. Prior to joining Shuimu Biosciences, she had postdoctoral trainings at MRC-LMB in the U.K. and NIH in the US in 2017-2020, working on mitochondrial outer membrane translocons and Parkinson's disease related<span  style="color:#232333;font-family:tahoma;font-size:14.0px;font-style:normal;font-variant-ligatures:normal;font-variant-caps:normal;font-weight:400;text-align:left;text-indent:.0px;text-transform:none;widows:2;background-color:#ffffff;text-decoration-thickness:initial;text-decoration-style:initial;text-decoration-color:initial;float:none;display:inline;"> α-syn fibril polymorphism. <span  style="color:#232333;font-family:tahoma;font-size:14.0px;font-style:normal;font-variant-ligatures:normal;font-variant-caps:normal;font-weight:400;text-align:left;text-indent:.0px;text-transform:none;widows:2;background-color:#ffffff;text-decoration-thickness:initial;text-decoration-style:initial;text-decoration-color:initial;float:none;display:inline;">As 1st author or co-author, her work had been published in more than 10 renowned journals including Nucleic Acids Research, Nature Communications, Structure, Communications Biology, JMB, JACS, </span></span><em ><span  style="color:#232333;font-family:tahoma;font-size:14.0px;font-variant-ligatures:normal;font-variant-caps:normal;font-weight:400;text-align:left;text-indent:.0px;text-transform:none;widows:2;background-color:#ffffff;text-decoration-thickness:initial;text-decoration-style:initial;text-decoration-color:initial;float:none;display:inline;">et al.</span></em></span></div><div  style="clear:both;"><br ></div><div  style="clear:both;"><span  style="font-family:tahoma;font-size:14.0px;">Thank you.</span></div><div  style="clear:both;"><span  style="font-family:tahoma;font-size:14.0px;">Kind regards,</span></div><div  style="clear:both;"><span  style="font-family:tahoma;font-size:14.0px;">Weiyan</span></div><div  style="clear:both;"><br ></div><div  style="clear:both;">Senior Director Business Development</div><div  style="clear:both;">Americas, EMEA, Asia Pacific</div><div  style="clear:both;">Shuimu Biosciences LTD</div><div  style="clear:both;">hi@shuimubio.com</div><div  style="clear:both;"><span  style="font-family:Tahoma,Arial,STHeiti,SimSun;font-size:14.0px;color:#000000;"><br ></span></div></div>